
Protalix BioTherapeutics, Inc.
PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31
Reports and events: 399 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2019-04-1217:00 ET | DEF 14A | Proxy statementPeriod 2019-05-30 | 0001144204-19-019545 |
| 2019-03-1809:02 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001144204-19-014464 |
| 2019-03-1807:20 ET | 10-Q/A | Quarterly report, amendedPeriod 2018-09-30 | 0001144204-19-014455 |
| 2019-03-1807:14 ET | 10-Q/A | Quarterly report, amendedPeriod 2018-06-30 | 0001144204-19-014453 |
| 2019-03-1807:07 ET | 10-Q/A | Quarterly report, amendedPeriod 2018-03-31 | 0001144204-19-014450 |
| 2019-03-1806:59 ET | 8-K | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001144204-19-014447 |
| 2019-02-0507:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-19-004918 |
| 2019-01-1016:05 ET | 8-K | 5.07 Shareholder vote results | 0001144204-19-001350 |
| 2019-01-0416:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-19-000672 |
| 2018-12-1707:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-18-064759 |
| 2018-12-1316:32 ET | 8-K | 5.07 Shareholder vote results | 0001144204-18-064451 |
| 2018-11-0716:31 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001144204-18-057990 |
| 2018-11-0707:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-18-057755 |
| 2018-10-1716:31 ET | DEF 14A | Proxy statementPeriod 2018-12-13 | 0001144204-18-054229 |
| 2018-10-0507:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-18-052605 |
| 2018-09-2111:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-18-050260 |
| 2018-08-1307:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001144204-18-043714 |
| 2018-08-0916:09 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001144204-18-043286 |
| 2018-08-0907:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-18-042980 |
| 2018-07-2416:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-18-039629 |
| 2018-05-3116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001144204-18-031991 |
| 2018-05-2416:05 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-18-030793 |
| 2018-05-1416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001144204-18-028177 |
| 2018-05-0916:07 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001144204-18-026625 |
| 2018-05-0907:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-18-026337 |
| 2018-04-1616:06 ET | 8-K | 5.07 Shareholder vote results | 0001144204-18-020721 |
| 2018-03-2116:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-18-016178 |
| 2018-03-0616:11 ET | DEF 14A | Proxy statementPeriod 2018-04-15 | 0001571049-18-000157 |
| 2018-03-0616:08 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001144204-18-013053 |
| 2018-03-0607:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-18-012946 |
| 2018-01-3107:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-18-004740 |
| 2018-01-0516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-18-001057 |
| 2017-12-0116:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001144204-17-061920 |
| 2017-11-2707:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-060846 |
| 2017-11-1307:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-057968 |
| 2017-11-0816:21 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001144204-17-057290 |
| 2017-11-0807:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-17-057015 |
| 2017-10-2009:01 ET | 8-K | 5.07 Shareholder vote results | 0001144204-17-053341 |
| 2017-10-1916:07 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-053226 |
| 2017-09-0116:04 ET | DEF 14A | Proxy statementPeriod 2017-10-19 | 0001144204-17-046387 |
| 2017-08-2516:30 ET | DEF 14A | Proxy statementPeriod 2017-10-19 | 0001144204-17-045196 |
| 2017-08-0916:18 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001144204-17-041693 |
| 2017-08-0907:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-17-041392 |
| 2017-07-2516:59 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-038121 |
| 2017-06-0707:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-031384 |
| 2017-05-1016:06 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001144204-17-026034 |
| 2017-05-1007:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-17-025800 |
| 2017-05-0907:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-025419 |
| 2017-04-1807:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-020803 |
| 2017-04-1216:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001144204-17-020173 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.